These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30160018)

  • 41. PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases.
    García-Díez I; Hernández-Ruiz E; Andrades E; Gimeno J; Ferrándiz-Pulido C; Yébenes M; García-Patos V; Pujol RM; Hernández-Muñoz I; Toll A
    Am J Dermatopathol; 2018 Sep; 40(9):647-654. PubMed ID: 29742559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic.
    Oguejiofor K; Galletta-Williams H; Dovedi SJ; Roberts DL; Stern PL; West CM
    Oncotarget; 2017 Feb; 8(9):14416-14427. PubMed ID: 28122336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Density and location of CD3
    Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
    J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value and clinicopathological status of PD-L1 expression and CD8+ TILs in oral squamous cell cancer patients with or without traditional risk factors.
    Soopanit T; Laokulrath N; Chayopasakul V; Pongsapich W
    Head Neck; 2023 Apr; 45(4):1017-1025. PubMed ID: 36811208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study.
    Troeltzsch M; Woodlock T; Pianka A; Otto S; Troeltzsch M; Ehrenfeld M; Knösel T
    J Oral Maxillofac Surg; 2017 May; 75(5):969-977. PubMed ID: 27916470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma.
    Malaspina TS; Gasparoto TH; Costa MR; de Melo EF; Ikoma MR; Damante JH; Cavassani KA; Garlet GP; da Silva JS; Campanelli AP
    Cancer Immunol Immunother; 2011 Jul; 60(7):965-74. PubMed ID: 21442435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof.
    Chen TC; Wu CT; Wang CP; Hsu WL; Yang TL; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2015 Nov; 51(11):1004-1010. PubMed ID: 26365985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of tumor PD-L1 expression combined with CD8
    Wang Q; Lou W; Di W; Wu X
    Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages.
    Jiang C; Yuan F; Wang J; Wu L
    Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
    Ubukata Y; Ogata K; Sohda M; Yokobori T; Shimoda Y; Handa T; Nakazawa N; Kimura A; Kogure N; Sano A; Sakai M; Ogawa H; Kuwano H; Shirabe K; Oyama T; Saeki H
    Oncology; 2021; 99(1):15-22. PubMed ID: 33113541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
    Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8⁺ T cells.
    Leng C; Li Y; Qin J; Ma J; Liu X; Cui Y; Sun H; Wang Z; Hua X; Yu Y; Li H; Zhang J; Zheng Y; Wang W; Zhu J; Wang Q
    Oncol Rep; 2016 Feb; 35(2):699-708. PubMed ID: 26718132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
    Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
    Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis.
    Tang H; Zhou X; Ye Y; Zhou Y; Wu C; Xu Y
    Pathol Res Pract; 2020 Jan; 216(1):152768. PubMed ID: 31837884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical study on neuropilin 1 (NRP1) immunoexpression in oral squamous cell carcinoma.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    Folia Histochem Cytobiol; 2018; 1(2):98-105. PubMed ID: 29873058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment.
    de Vicente JC; Lequerica-Fernández P; Rodrigo JP; Rodríguez-Santamarta T; Blanco-Lorenzo V; Prieto-Fernández L; Corte-Torres D; Vallina A; Domínguez-Iglesias F; Álvarez-Teijeiro S; García-Pedrero JM
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
    Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD163
    Shigeoka M; Koma YI; Nishio M; Komori T; Yokozaki H
    Clin Exp Dent Res; 2019 Dec; 5(6):627-637. PubMed ID: 31890299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Takakura H; Domae S; Ono T; Sasaki A
    Acta Med Okayama; 2017 Jun; 71(3):219-226. PubMed ID: 28655941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.